Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension

Journal of Thoracic Disease

Meghan M. Cirulis¹  John J. Ryan¹ 

[1] Division of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT, USADivision of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT, USADivision of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT, USA

关键词: Warfarin;    pulmonary hypertension;    randomized registry trial;    prostacyclins;    vitamin K antagonists (VKA);   

DOI  :  10.21037/jtd.2016.03.67

学科分类：呼吸医学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown